Studio Investment Management’s Bristol-Myers Squibb BMY Stock Holding History

Studio Investment Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-500	Closed	-$30.5K	–	184
2025 Q1	$30.5K	Hold	500	–	–	0.01%	219
2024 Q4	$28.3K	Hold	500	–	–	0.01%	216
2024 Q3	$25.9K	Sell	500 -392	-44%	-$18.4K	0.01%	215
2024 Q2	$37K	Hold	892	–	–	0.01%	192
2024 Q1	$48.4K	Hold	892	–	–	0.01%	185
2023 Q4	$45.8K	Hold	892	–	–	0.01%	178
2023 Q3	$51.8K	Hold	892	–	–	0.01%	169
2023 Q2	$57K	Hold	892	–	–	0.02%	161
2023 Q1	$61.8K	Buy	892 +392	+78%	+$27.6K	0.02%	147
2022 Q4	$36K	Hold	500	–	–	0.01%	140
2022 Q3	$35.5K	Hold	500	–	–	0.01%	140
2022 Q2	$39K	Buy	+500	New	+$38.1K	0.01%	144

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Studio Investment Management's BMY Position: Q2 2025 in Review

Studio Investment Management sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 500 shares — an estimated $30.5K sold.

Studio Investment Management first reported a position in BMY in Q2 2022 and held it in 12 quarters. The position peaked at $61.8K in Q1 2023. 2,299 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

Studio Investment Management reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
Studio Investment Management sold 500 Bristol-Myers Squibb shares in Q2 2025, an estimated $30.5K.
Studio Investment Management first reported a position in Bristol-Myers Squibb in Q2 2022 and held it in 12 quarters.
Studio Investment Management's Bristol-Myers Squibb position peaked at $61.8K in Q1 2023.
2,299 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Studio Investment Management's 13F filing for Q2 2025, filed 30 Jul 2025.